About UAS Labs
UAS Labs is a Healthcare company based in Wausau (United States) founded in 1979, and was acquired by Chr. Hansen in June 2020. Clinical research and probiotic fermentation services are provided. UAS Labs has raised $31.75 million across 4 funding rounds from investors including Chr. Hansen and Greyrock Capital Group. UAS Labs has completed 2 acquisitions, including Micropharma and Nebraska Cultures. Its Indian entity Uas Life Sciences India Private Limited reported revenue of ₹3.25 Cr. Its focus areas include Biopharma Outsourcing, Diversified and Small Molecules & Peptides. Its competitors include Pfizer, LabConnect and Ainos; 2 of its 3 listed competitors have raised funding.
Company details
UAS Labs was founded in 1979 and is headquartered in Wausau, United States. Operations are centered in the biotechnology sector, with a focus on clinical research services and probiotic fermentation processes. These services support product development for health and nutrition applications. The company maintains facilities for research and manufacturing, serving clients in the probiotic and microbiome industries across North America.
- Headquarters Wausau, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website uaslabs.com
- Social LinkedIn
- Acquired by Chr. Hansen (Jun 2020)
- Legal Name Uas Life Sciences India Private Limited
- Date of Incorporation 21 Mar, 2014
- Jurisdiction Secunderabad, Telangana, India
- Indian entity revenue₹3.25 Cr
FY 2025 · +1961% YoY
- Indian entity net profit₹2.70 Cr
FY 2025 · 83% margin
- Indian entity EBITDA₹3.15 Cr
FY 2025 · 97% margin
- Total Equity Funding$31.75M (USD)
in 4 rounds
- Latest Funding Round$4.5M (USD), Series B
Feb 2019
- InvestorsChr. Hansen
& 1 more
- Investments & AcquisitionsMicropharma
& 1 more
- Acquired byChr. Hansen
(Jun 2020)
Associated legal entities of UAS Labs
UAS Labs operates through Uas Life Sciences India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Uas Life Sciences India Private Limited CIN U51397TG2014FTC093664 | Active | 21 Mar 2014 | Secunderabad, Telangana | ₹3.3 Cr | 2 | View details |
Funding Insights of UAS Labs
UAS Labs has successfully raised a total of $31.75M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $4.5 million completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $31.75M
- Total Rounds 4
- Last Round Series B — $4.5M
- First Round $6M
(Apr 2013)
- Investors Count 1
All 4 funding rounds of UAS Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2019 | $4.5M | Series B | – | – | – |
| Feb 2017 | $21.25M | Series B | – | – | – |
| Apr 2013 | $6M | Series A | – | Greyrock Capital Group | – |
| Apr 2013 | Debt – Conventional | – | – |
2 investors in total: 2 institutional.
Investors in UAS Labs
UAS Labs has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Chr. Hansen and Greyrock Capital Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provision of stable capital to private equity sponsors for investments. | greyrockcapitalgroup.com | |||
Developer of natural solutions for the food, nutritional, pharmaceutical and agricultural industries. | 1843 | chr-hansen.com | Copenhagen, Denmark |
Investor details for UAS Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Uas Life Sciences India Private Limited (UAS Labs)
Uas Life Sciences India Private Limited is the primary company behind UAS Labs. The board of Uas Life Sciences India Private Limited currently have 2 directors; the longest-serving is Richa Kailashchandra Sharma, appointed in 2020. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Richa Kailashchandra Sharma DIN 07509199 | Director | 27 Jul 2020 | 6 yrs 3 mo | Uas Life Sciences India Private Limited |
| Krishnamohan Puvvada DIN 08545776 | Director | 04 Sep 2024 | 2 yrs 2 mo | Uas Life Sciences India Private Limited |
People of UAS Labs
1 people are tracked at UAS Labs (1 in leadership).
| Name | Role | Group |
|---|---|---|
冰冰 范 | ceo | Leadership |
Complete people profiles for UAS Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of UAS Labs
Figures of Uas Life Sciences India Private Limited, the primary company behind UAS Labs, for FY 2025. Revenue was ₹3.25 Cr (+1961% year on year). Net profit was ₹2.70 Cr (83% margin). EBITDA was ₹3.15 Cr (97% margin). Revenue has grown at a compounded annual rate of +163% over three years and +24% over five years.
- ₹3.25 CrRevenue · FY 2025 · +1961% YoY
- ₹2.70 CrNet profit · 83% margin
- ₹3.15 CrEBITDA · 97% margin
- ₹21 LakhPaid-up capital
- +163%Revenue CAGR, 3 years
- +24%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Uas Life Sciences India Private Limited are on its company page.
Detailed financial statements for UAS Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by UAS Labs
UAS Labs has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Micropharma and Nebraska Cultures.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Information on various diseases is delivered via an online platform. | nebraskacultures.com | Walnut Creek, United States | 1981 | Apr 2018 | •••• | |
Biotherapeutics for metabolic diseases are developed from bacteria. | micropharma.net | Montreal, Canada | 2004 | Dec 2014 | •••• |
Complete acquisition details for UAS Labs
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of UAS Labs
6 dated milestones of UAS Labs across 41 years, from founding to its latest funding, stage changes and deals.
- Founded UAS Labs is founded.
- Funding First funding round of $6.0M.
- Acquisition Acquires Micropharma.
- Acquisition Acquires Nebraska Cultures.
- Funding Latest funding round, Series B, of $4.5M.
- Exit Acquired by Chr. Hansen.
Competitors of UAS Labs
UAS Labs has 3 listed competitors in our database, 2 of them funded. They include Pfizer, LabConnect and Ainos.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pfizer.com | 1849 | New York, United States | $8M | Pharmaceutical products for treating multiple diseases are provided. | ||
| labconnect.com | 2002 | Johnson, United States | $28.5M | Laboratory testing, clinical trial research, and biopharma services are provided. | ||
| ainos.com | 1986 | San Diego, United States | 43 | Novel point-of-care testing and low-dose interferon therapeutics are developed. |
Detailed competitors of UAS Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of UAS Labs
Websites that share an audience with UAS Labs (uaslabs.com).
Websites whose visitors overlap most with UAS Labs. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
nutraceutix.net | nutraceutix.net | 100% | – | ||
| nationalenzyme.com | 98% | View details | |||
soft-gel.com | soft-gel.com | 87% | #2,494,936 | – | |
up4probiotics.com | up4probiotics.com | 78% | – | ||
| traceminerals.com | 76% | 87.9K | #400,536 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for UAS Labs
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as UAS Labs (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Uas Labs
Complete news archive for UAS Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about UAS Labs
UAS Labs was founded in 1979 and raised its 1st funding round 34 years after it was founded.
UAS Labs is headquartered in Wausau, United States. It is registered at Wausau, Wisconsin, United States.
UAS Labs is a funded company, having raised a total of $31.75M across 4 funding rounds to date. The company's 1st funding round was a Series A of $6M, raised on Apr 2013.
The primary company behind UAS Labs, Uas Life Sciences India Private Limited, reported revenue of ₹3.25 Cr for FY 2025, up 1961% year on year.
UAS Labs was founded in 1979 and is headquartered in Wausau, United States. Operations are centered in the biotechnology sector, with a focus on clinical research services and probiotic fermentation processes. These services support product development for health and nutrition applications. The company maintains facilities for research and manufacturing, serving clients in the probiotic and microbiome industries across North America.
UAS Labs's top competitors include Pfizer, LabConnect and Ainos.
UAS Labs has made 2 acquisitions, including Micropharma, and Nebraska Cultures.
UAS Labs has 2 investors. Key investors include Chr. Hansen, and Greyrock Capital Group.
UAS Labs operates through Uas Life Sciences India Private Limited.
Yes. UAS Labs was acquired by Chr. Hansen in June 2020.
The legal entities of UAS Labs currently have 2 directors, including Krishnamohan Puvvada, Richa Kailashchandra Sharma.